Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1056122.RAYnnzc4jMTzcetHtoE00jN6tgXFgWrW_-axsBAuZgYs4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1056122.RAYnnzc4jMTzcetHtoE00jN6tgXFgWrW_-axsBAuZgYs4130_assertion type Assertion NP1056122.RAYnnzc4jMTzcetHtoE00jN6tgXFgWrW_-axsBAuZgYs4130_head.
- NP1056122.RAYnnzc4jMTzcetHtoE00jN6tgXFgWrW_-axsBAuZgYs4130_assertion description "[It is not well defined whether the addition of anti-VEGF and anti-EGFR to chemotherapy could improve outcome in those patients susceptible to CRC-related metastases resection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056122.RAYnnzc4jMTzcetHtoE00jN6tgXFgWrW_-axsBAuZgYs4130_provenance.
- NP1056122.RAYnnzc4jMTzcetHtoE00jN6tgXFgWrW_-axsBAuZgYs4130_assertion evidence source_evidence_literature NP1056122.RAYnnzc4jMTzcetHtoE00jN6tgXFgWrW_-axsBAuZgYs4130_provenance.
- NP1056122.RAYnnzc4jMTzcetHtoE00jN6tgXFgWrW_-axsBAuZgYs4130_assertion SIO_000772 23441760 NP1056122.RAYnnzc4jMTzcetHtoE00jN6tgXFgWrW_-axsBAuZgYs4130_provenance.
- NP1056122.RAYnnzc4jMTzcetHtoE00jN6tgXFgWrW_-axsBAuZgYs4130_assertion wasDerivedFrom befree-2016 NP1056122.RAYnnzc4jMTzcetHtoE00jN6tgXFgWrW_-axsBAuZgYs4130_provenance.
- NP1056122.RAYnnzc4jMTzcetHtoE00jN6tgXFgWrW_-axsBAuZgYs4130_assertion wasGeneratedBy ECO_0000203 NP1056122.RAYnnzc4jMTzcetHtoE00jN6tgXFgWrW_-axsBAuZgYs4130_provenance.